
Briciclib
CAS No. 865783-99-9
Briciclib( ON 014185 )
Catalog No. M19193 CAS No. 865783-99-9
Briciclib is a small molecule that suppresses cyclin D1 accumulation in Y cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 47 | In Stock |
![]() ![]() |
5MG | 72 | In Stock |
![]() ![]() |
10MG | 115 | In Stock |
![]() ![]() |
25MG | 237 | In Stock |
![]() ![]() |
50MG | 356 | In Stock |
![]() ![]() |
100MG | 530 | In Stock |
![]() ![]() |
500MG | 1152 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBriciclib
-
NoteResearch use only, not for human use.
-
Brief DescriptionBriciclib is a small molecule that suppresses cyclin D1 accumulation in Y cells.
-
DescriptionBriciclib is a small molecule that suppresses cyclin D1 accumulation in Y cells.(In Vitro):Briciclib has the potential in targeting eIF4E. Briciclib shows inhibitory activity against the proliferation of mantle cell leukemia (EKO-1 and MINO), breast (MCF7 and MDA-MB-231), gastric (AGS), and esophageal (OE19, OE33, and FLO-1) cancer cell lines with GI50s of 9.8-12.2 nM, and with no toxicity on normal endothelial cells. Briciclib dose-dependently reduces the expression of cyclin D1 and c-Myc in breast and MCL cancer cell lines within 8 hours.
-
In VitroBriciclib has the potential in targeting eIF4E. Briciclib shows inhibitory activity against the proliferation of mantle cell leukemia (EKO-1 and MINO), breast (MCF7 and MDA-MB-231), gastric (AGS), and esophageal (OE19, OE33, and FLO-1) cancer cell lines with GI50s of 9.8-12.2 nM, and with no toxicity on normal endothelial cells. Briciclib dose-dependently reduces the expression of cyclin D1 and c-Myc in breast and MCL cancer cell lines within 8 hours.
-
In Vivo——
-
SynonymsON 014185
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorCyclin D1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number865783-99-9
-
Formula Weight474.42
-
Molecular FormulaC19H23O10PS
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 31 mg/mL; 65.34 mM
-
SMILESc1(cc(c(c(c1)OC)/C=C/S(=O)(=O)Cc1ccc(c(c1)OP(=O)(O)O)OC)OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Neel Jasani, et al. DOI: 10.1158/1538-7445.
molnova catalog



related products
-
Plinabulin
Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.
-
6-MOMIPP
6-MOMIPP is a novel microtubule disruptor that targets the colchicine binding site on β-tubulin, induces mitotic arrest, caspase activation and loss of cell viability of U251 glioblastoma in vitro.
-
Decanoic Acid
Decanoic Acid acts as a non-competitive AMPA receptor antagonist.